2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Cortical and subcortical morphometric changes and their relation to cognitive impairment in isolated REM sleep behavior disorder

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          To date, very few studies have focused on structural changes and their association with cognitive performance in isolated REM sleep behaviour disorder (iRBD). Moreover, the results of these studies are inconclusive. This study aims to evaluate differences in the associations between brain morphology and cognitive tests in iRBD and healthy controls.

          Methods

          Sixty-three patients with iRBD and thirty-six controls underwent MRI with a 3 T scanner. The cognitive performance was assessed by a comprehensive neuropsychological battery. Based on performance, the iRBD group was divided into two subgroups with (iRBD-MCI) and without mild cognitive impairment (iRBD-NC). The high-resolution T1-weighted images were analysed using an automated atlas segmentation tool, voxel-based (VBM) and deformation-based (DBM) morphometry to identify between-group differences and correlations with cognitive performance.

          Results

          VBM, DBM and the comparison of ROI volumes yielded no significant differences between iRBD and controls. In the iRBD group, significant correlations in VBM were found between several cortical and subcortical structures primarily located in the temporal, parietal, occipital lobe, cerebellum, and basal ganglia and three cognitive tests assessing psychomotor speed and one memory test. Between-group analysis of cognition revealed a significant difference between iRBD-MCI and iRBD-NC in tests including a processing speed component.

          Conclusions

          iRBD shows deficits in several cognitive tests that correlate with morphological changes, the most prominent of which is in psychomotor speed and visual attention as measured by the TMT-A and associated with the volume of striatum, insula, cerebellum, temporal lobe, pallidum and amygdala.

          Supplementary Information

          The online version contains supplementary material available at 10.1007/s10072-023-07040-z.

          Related collections

          Most cited references31

          • Record: found
          • Abstract: found
          • Article: not found

          A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

          The development and use of a new scale, the Epworth sleepiness scale (ESS), is described. This is a simple, self-administered questionnaire which is shown to provide a measurement of the subject's general level of daytime sleepiness. One hundred and eighty adults answered the ESS, including 30 normal men and women as controls and 150 patients with a range of sleep disorders. They rated the chances that they would doze off or fall asleep when in eight different situations commonly encountered in daily life. Total ESS scores significantly distinguished normal subjects from patients in various diagnostic groups including obstructive sleep apnea syndrome, narcolepsy and idiopathic hypersomnia. ESS scores were significantly correlated with sleep latency measured during the multiple sleep latency test and during overnight polysomnography. In patients with obstructive sleep apnea syndrome ESS scores were significantly correlated with the respiratory disturbance index and the minimum SaO2 recorded overnight. ESS scores of patients who simply snored did not differ from controls.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

            We present a clinimetric assessment of the Movement Disorder Society (MDS)-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS). The MDS-UDPRS Task Force revised and expanded the UPDRS using recommendations from a published critique. The MDS-UPDRS has four parts, namely, I: Non-motor Experiences of Daily Living; II: Motor Experiences of Daily Living; III: Motor Examination; IV: Motor Complications. Twenty questions are completed by the patient/caregiver. Item-specific instructions and an appendix of complementary additional scales are provided. Movement disorder specialists and study coordinators administered the UPDRS (55 items) and MDS-UPDRS (65 items) to 877 English speaking (78% non-Latino Caucasian) patients with Parkinson's disease from 39 sites. We compared the two scales using correlative techniques and factor analysis. The MDS-UPDRS showed high internal consistency (Cronbach's alpha = 0.79-0.93 across parts) and correlated with the original UPDRS (rho = 0.96). MDS-UPDRS across-part correlations ranged from 0.22 to 0.66. Reliable factor structures for each part were obtained (comparative fit index > 0.90 for each part), which support the use of sum scores for each part in preference to a total score of all parts. The combined clinimetric results of this study support the validity of the MDS-UPDRS for rating PD.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.

              Mild cognitive impairment is common in nondemented Parkinson's disease (PD) patients and may be a harbinger of dementia. In view of its importance, the Movement Disorder Society commissioned a task force to delineate diagnostic criteria for mild cognitive impairment in PD. The proposed diagnostic criteria are based on a literature review and expert consensus. This article provides guidelines to characterize the clinical syndrome and methods for its diagnosis. The criteria will require validation, and possibly refinement, as additional research improves our understanding of the epidemiology, presentation, neurobiology, assessment, and long-term course of this clinical syndrome. These diagnostic criteria will support future research efforts to identify at the earliest stage those PD patients at increased risk of progressive cognitive decline and dementia who may benefit from clinical interventions at a predementia stage. Copyright © 2012 Movement Disorder Society.
                Bookmark

                Author and article information

                Contributors
                filip.havlik.kv@gmail.com
                Journal
                Neurol Sci
                Neurol Sci
                Neurological Sciences
                Springer International Publishing (Cham )
                1590-1874
                1590-3478
                5 September 2023
                5 September 2023
                2024
                : 45
                : 2
                : 613-627
                Affiliations
                [1 ]Department of Biomedical Informatics, Faculty of Biomedical Engineering, Czech Technical University in Prague, ( https://ror.org/03kqpb082) Prague, Czech Republic
                [2 ]GRID grid.411798.2, ISNI 0000 0000 9100 9940, Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, , Charles University and General University Hospital, ; Prague, Czech Republic
                [3 ]Department of Radiology, Na Homolce Hospital, ( https://ror.org/00w93dg44) Prague, Czech Republic
                Author information
                http://orcid.org/0000-0001-5440-8712
                http://orcid.org/0000-0003-4442-6743
                http://orcid.org/0000-0002-7817-3978
                http://orcid.org/0000-0002-3339-5286
                http://orcid.org/0000-0002-4421-9958
                http://orcid.org/0000-0002-4893-9661
                http://orcid.org/0000-0001-5773-9656
                http://orcid.org/0000-0002-6799-7840
                http://orcid.org/0000-0002-9732-8947
                http://orcid.org/0000-0003-4877-9642
                http://orcid.org/0000-0002-5108-0181
                http://orcid.org/0000-0002-0280-215X
                Article
                7040
                10.1007/s10072-023-07040-z
                10791856
                37670125
                7390a5c8-70bd-4323-b068-e7550795a0d1
                © The Author(s) 2023

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 12 May 2023
                : 24 August 2023
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100003243, Ministerstvo Zdravotnictví Ceské Republiky;
                Award ID: NU20-04-00327
                Award ID: NU21-04-00535
                Funded by: National Institute for Neurological Research
                Award ID: LX22NPO5107
                Funded by: FundRef http://dx.doi.org/10.13039/100007397, Univerzita Karlova v Praze;
                Award ID: MH CZ-DRO-VFN64165
                Award ID: MH CZ-DRO-NNH00023884
                Categories
                Original Article
                Custom metadata
                © Fondazione Società Italiana di Neurologia 2024

                Neurosciences
                mild cognitive impairment,prodromal,synucleinopathy,cognition,trail making test,rem sleep without atonia

                Comments

                Comment on this article